Health outcomes following COVID-19 infection and vaccination in hereditary hemorrhagic telangiectasia
Our results suggest that HHT patients are not at higher risk of severe infection with COVID-19 compared to the general population. Vaccination rates are high with only mild side effects being observed.
Authors
- Marianne S. Clancy (ORCID: https://orcid.org/0000-0001-9394-9271)
- Xiayi Ma (ORCID: https://orcid.org/0000-0003-3504-7637)
- Marie E. Faughnan (ORCID: https://orcid.org/0000-0002-3746-383X)
- Kamalprit Chokar
- Nicholas T. Vozoris (ORCID: https://orcid.org/0000-0003-1670-1592)
- Christopher M. Tarulli (ORCID: https://orcid.org/0009-0004-5891-2157)
Institutions
- St. Michael's Hospital (CA)
- University of Toronto (CA)
Publication Details
- Journal
- Orphanet Journal of Rare Diseases
- Published
- 2025-03-01
- DOI
- https://doi.org/10.1186/s13023-025-03561-2
- Primary Topic
- Vascular Anomalies and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00